Stay updated on Melanoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Melanoma Immunotherapy Clinical Trial page.

Latest updates to the Melanoma Immunotherapy Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded an Erratum reference for the NEJM 2015 publication on Combined Nivolumab and Ipilimumab (CheckMate 067) to the Publications section.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.4.2 was added to the page; the government funding notice and the revision entry for v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check45 days agoChange DetectedAdded a government funding notice at the top of the page. Updated Publications with a new author list for the CheckMate 067-related publication and a revision tag (v3.4.1); removed the previous publication entry (v3.4.0) containing an erratum.SummaryDifference0.2%

- Check52 days agoChange DetectedAdded a glossary toggle and updated metadata to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' with capitalization changes. Removed older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'.SummaryDifference0.1%

Stay in the know with updates to Melanoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Melanoma Immunotherapy Clinical Trial page.